Literature DB >> 6394124

Diet and monoamine oxidase inhibitors: a re-examination.

E A Sullivan, K I Shulman.   

Abstract

Monoamine oxidase inhibitors (MAOIs) are attracting renewed attention as effective antidepressants for refractory depressions, particularly among the elderly. However, widespread fears concerning the interactions of MAOIs with tyramine-containing foods have led to the development of long and complicated diets. These diets have served as an obstacle to the ready use of MAOIs, yet very little systematic or critical review of the basis for food restriction has been undertaken. An international survey of MAOI diets was conducted and from the diets collected, foods were categorized according to frequency of restriction on the diet lists. On the basis of this survey and a critical review of the literature it was determined that only four foods clearly warrant absolute prohibition: aged cheese, pickled fish (herring), concentrated yeast extracts and broad bean pods. While there is insufficient evidence to prohibit alcohol completely (even chianti wine) true moderation must apply. It is suggested that a radically simplified diet should be investigated on a prospective basis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6394124     DOI: 10.1177/070674378402900814

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  9 in total

1.  The role of monoamine oxidase inhibitors in current psychiatric practice.

Authors:  Jess G Fiedorowicz; Karen L Swartz
Journal:  J Psychiatr Pract       Date:  2004-07       Impact factor: 1.325

Review 2.  Predicting drug metabolism: experiment and/or computation?

Authors:  Johannes Kirchmair; Andreas H Göller; Dieter Lang; Jens Kunze; Bernard Testa; Ian D Wilson; Robert C Glen; Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2015-04-24       Impact factor: 84.694

Review 3.  Monoamine oxidase inhibitor update. Potential adverse food and drug interactions.

Authors:  S B Lippman; K Nash
Journal:  Drug Saf       Date:  1990 May-Jun       Impact factor: 5.606

4.  The pharmacological management of depression.

Authors:  R T Joffe
Journal:  Can Fam Physician       Date:  1986-06       Impact factor: 3.275

Review 5.  Monoamine oxidase inhibitors. An update on drug interactions.

Authors:  M G Livingston; H M Livingston
Journal:  Drug Saf       Date:  1996-04       Impact factor: 5.606

6.  Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects.

Authors:  I Berlin; R Zimmer; H M Thiede; C Payan; T Hergueta; L Robin; A J Puech
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

7.  Evaluation and comparison of the interaction between alcohol and moclobemide or clomipramine in healthy subjects.

Authors:  I Berlin; A Cournot; R Zimmer; A M Pedarriosse; R Manfredi; P Molinier; A J Puech
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 8.  Computational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanisms.

Authors:  Johannes Kirchmair; Mark J Williamson; Jonathan D Tyzack; Lu Tan; Peter J Bond; Andreas Bender; Robert C Glen
Journal:  J Chem Inf Model       Date:  2012-02-17       Impact factor: 4.956

Review 9.  Current place of monoamine oxidase inhibitors in the treatment of depression.

Authors:  Kenneth I Shulman; Nathan Herrmann; Scott E Walker
Journal:  CNS Drugs       Date:  2013-10       Impact factor: 5.749

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.